Rate of 6‐[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease
- 29 March 2011
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 26 (4) , 614-620
Abstract
Background: Rate of decline in 6‐L‐[18F]fluorodopa (FDOPA) uptake within the striatum has been reported as showing regional differences in Parkinson's disease (PD).Methods: We acquired longitudinal brain FDOPA positron emission tomography (PET) studies in 26 PD subjects and 11 controls over 4.5 years. We analyzed both spatially normalized voxel‐wise maps of radiotracer influx (Kocc) and average Kocc values for six non‐overlapping volumes of interest (VOIs) encompassing the striatum.Results: The voxel‐wise analysis showed that in PD, FDOPA Kocc decline spanned the striatum but was greatest in the posterior putamen ipsilateral and anterior putamen contralateral to initial symptoms. The VOI approached showed that absolute rates of Kocc decline were significantly greater in PD than control subjects, but that the slope of decline did not differ between subregions. In PD, ratios of uptake between subregions did not change during the study with the exception of the ipsilateral putamen/caudate ratio. Decline rates were marginally greater during earlier time segments. Both male gender and advancing age were associated with lower baseline FDOPA uptake, but no difference in decline rates. VOI Kocc values were significantly correlated with disease duration, but only moderately correlated with clinical measures.Discussion: We conclude that FDOPA uptake in subregions of the striatum is strongly correlated with disease duration and age, and declines approximately equally from symptom onset in PD. This implies that in idiopathic PD, relative preservation of uptake in the anterior striatum reflects a delay in pathologic involvement of nigrostriatal projections to this region. © 2011 Movement Disorder SocietyKeywords
This publication has 31 references indexed in Scilit:
- Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory MechanismsJournal of Cerebral Blood Flow & Metabolism, 2004
- Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's diseaseActa Neurologica Scandinavica, 2004
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET studyAnnals of Neurology, 2003
- Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PETSynapse, 2003
- Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET studyMovement Disorders, 2001
- Increased frontal [18F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortexBrain, 2001
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- Central Dopaminergic Pathways in Hemiparkinsonism Examined by Positron Emission TomographyCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1984
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake DataJournal of Cerebral Blood Flow & Metabolism, 1983
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973